Pharmaceutical, biotechnology and medical products companies
May 16, 2019

Accenture Introduces INTIENT™, an Innovative Platform to Advance the Discovery, Development and Delivery of Patient Treatments

NEW YORK; May 16, 2019 – Accenture (NYSE: ACN) today introduced INTIENT™, a technology platform that vastly improves the continuity and flow of data across life sciences enterprises, supporting the delivery of ground-breaking treatments for patients. 
May 01, 2019

Accenture Completes Acquisition of ESP

NEW YORK and DUBLIN, Ireland; May 1, 2019 – Accenture (NYSE: ACN) has completed the acquisition of Enterprise System Partners (ESP), a consulting and manufacturing services provider for the life sciences industry that is headquartered in Cork, Ireland.
April 04, 2019

“New Science” is Leading Growth While Changing the Market Dynamics of the Biopharma Industry, According to New Research from Accenture

NEW YORK; April 4, 2019 – The adoption of a unique combination of the best in science and health technology such as genomics, biomarkers and companion technologies are expected to be the biopharmaceutical industry’s new growth machine, according to new research from Accenture (NYSE: ACN).
March 05, 2019

Accenture to Acquire ESP to Help Life Sciences Clients Digitize and Transform Manufacturing Operations

NEW YORK and DUBLIN, Ireland; Mar. 5, 2019 – Accenture (NYSE: ACN) has agreed to acquire Enterprise System Partners (ESP), a consulting and manufacturing services provider for the life sciences industry that is headquartered in Cork, Ireland, serving clients around the globe. Upon close, ESP will join Accenture Industry X.0, which helps clients master the digital reinvention of industry, strengthening Accenture’s capabilities to transform manufacturing for pharmaceutical, biotech and medical device clients globally.
January 08, 2019

Ayasdi Named Accenture HealthTech Innovation Challenge Innovation Champion

SAN FRANCISCO; Jan. 8, 2019 – Ayasdi has been named the Accenture HealthTech Innovation Challenge Innovation Champion, competing with more than 1,100 companies for the title. The competition pairs leading-edge startups with prominent health and life sciences organizations to develop innovative technology solutions that improve the way people access and manage healthcare.
December 21, 2018

Four Finalists in US and Canada Selected for Accenture HealthTech Innovation Challenge

NEW YORK; Dec. 21, 2018 – Using conversational artificial intelligence to improve care management and leveraging patient experiences to incentivize patients in their own health journey are among the innovative solutions being developed by the four North America-based finalists selected for the Accenture HealthTech Innovation Challenge.
December 11, 2018

Pierre Fabre Turns to Accenture to Digitize Corporate and Manufacturing Functions with SAP® S/4HANA®

PARIS; Dec. 11, 2018 – Pierre Fabre has selected Accenture (NYSE: ACN) to build an intelligent information technology (IT) platform to support and improve the performance of a range of functions including finance, accounting, procurement, order management and manufacturing  essential to the company’s global operations. The program is part of one of the most significant and strategic transformation initiatives ever undertaken at the French multinational health and beauty care company.
November 26, 2018

Accenture Expands Platform for Drug Discovery and Innovation with Creation of Life Sciences Partner Ecosystem

NEW YORK and LAS VEGAS; Nov. 26, 2018 – Accenture (NYSE: ACN) has created an open partner ecosystem designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and, ultimately, improve patient outcomes.
September 21, 2018

Accenture Introduces Ella and Ethan, AI Bots to Improve a Patient’s Health and Care Using the Accenture Intelligent Patient Platform

NEW YORK; Sept. 21, 2018 – Accenture (NYSE: ACN) has enhanced the Accenture Intelligent Patient Platform with the addition of Ella and Ethan, two interactive virtual-assistant bots that use artificial intelligence (AI) to constantly learn and make intelligent recommendations for interactions between life sciences companies, patients, health care providers (HCPs) and caregivers. Designed to help improve a patient’s health and overall experience, the bots are part of Accenture’s Salesforce Fullforce Solutions powered by Salesforce Health Cloud and Einstein AI, as well as Amazon’s Alexa.  
September 17, 2018

Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research

NEW YORK; Sept. 17, 2018 – Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development.